Spot Biosystems
Develops non-viral gene therapy using extracellular vesicle delivery platform for genetic medicines
$40MSeries B
Role not disclosedLoading investors…
Loading investors…
Activity from announced rounds
Develops non-viral gene therapy using extracellular vesicle delivery platform for genetic medicines
Builds open-source AI inference and training infrastructure, commercializing the SGLang engine
Provides AI observability and security platform for enterprises